Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.265 USD | -0.39% | -5.24% | -32.71% |
May. 15 | HC Wainwright Adjusts IO Biotech Price Target to $12 From $8, Maintains Buy Rating | MT |
May. 14 | IO Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.71% | 83.67M | |
+51.71% | 63.85B | |
-2.50% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.30% | 26.52B | |
-21.51% | 18.69B | |
+2.70% | 12.73B | |
+22.07% | 12.11B | |
+27.48% | 12.07B |
- Stock Market
- Equities
- IOBT Stock
- News IO Biotech, Inc.
- Transcript : IO Biotech, Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-12-2023 04